Download free PDF

Brain Implants Market Size & Share 2024 to 2032

Market Size by Type (Deep Brain Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators), by Application (Chronic Pain, Epilepsy, Parkinson’s Disease, Depression, Essential Tremor, Alzheimer’s Disease), by End Use (Hospitals.

Report ID: GMI3855
   |
Published Date: June 2023
 | 
Report Format: PDF

Download Free PDF

Brain Implants Market Size

Brain Implants Market size was valued at over USD 5.1 billion in 2023 and is projected to grow at a CAGR of 9% from 2024 to 2032. Brain implants, also known as neural implants or neuroprosthetics, are medical devices that are surgically implanted into the brain to restore or enhance brain function. These implants can interface with the brain's neural circuits to stimulate or record neural activity. The prevalence of neurological disorders has been on the rise in recent years.

Brain Implants Market Key Takeaways

Market Size & Growth

  • 2023 Market Size: USD 5.1 Billion
  • 2032 Forecast Market Size: USD 10.9 Billion
  • CAGR (2024–2032): 9%

Key Market Drivers

  • Increase in the prevalence of neurological disorders.
  • Growing demand for minimally invasive neurosurgical procedures.
  • Technological advancements in devices.
  • Growing geriatric population base.

Challenges

  • High cost of devices.
  • Surgical risks and complexity in implant procedure.

As the global population ages, the prevalence of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and stroke, increases. Age is a significant risk factor for varied neurological conditions, and with longer life expectancies, more people are living to an age where they are more likely to be susceptible to these disorders. Thus, the growing prevalence of neurological disorders increases the demand for brain implants among the geriatric population base.

Furthermore, the rising demand for minimally invasive neurological procedures owing to the surge in the prevalence of neurological disorders. For instance, according to the World Health Organization (WHO), neurological illnesses are one of the leading causes of death worldwide, accounting for 13.2% of fatalities in affluent nations and 16.8% in low- and middle-income nations. Additionally, they also contribute 6.3% to the global disease burden. This has led to clinical urgency for the implementation of long-term solutions such as spinal cord stimulators and deep brain stimulators.
 

COVID-19 Impact

The COVID-19 pandemic considerably impacted the advancement of the market, owing to the interruption and delay of most elective surgeries and procedures. According to the study published in medRXiV, 2021, the prevalence of SARS-COV2 infection in patients with Parkinson's disorder was estimated to be 11.28%. Additionally, it was discovered that 18.18% of Parkinson's disorder patients receiving deep brain stimulation had COVID-19 prevalence. As a result, COVID-19 patients pose a significant risk of experiencing neurological problems while they are receiving hospital care. The strict lockdown restrictions and measures taken to prohibit the viral transmission raised the chronic stress and burden of neurological disorders. This enhanced the need for neurological outpatient services to open.
 

Brain Implants Market

Brain implants Market Trends

The market is anticipated to be driven by the introduction of cutting-edge technologies such as Medtronic's MRI-safe brain implants and Neurowave Medical Technologies' transdermal neuromodulation technology. Additionally, technology including brain computer interfaces (BCIs), microelectrode arrays, and motor neuron prosthesis have advantages in enhanced patient mobility profiles. For instance, smart neural microchips strengthen the wireless transfer of brain signals into hands and fingers with approximately 95% precision.
 

Brain Implants Market Analysis

Brain Implants Market Size, By Type,

Based on type, the brain implants market is segmented into deep brain stimulators, spinal cord stimulators, vagus nerve stimulators. The deep brain stimulators segment witnessed the largest revenue size over USD 1 billion in 2022 and is estimated to witness significant development more than USD 4 billion by 2032. Deep brain stimulators (DBS) are a type of brain implant that uses electrical stimulation to modulate neural activity in specific regions of the brain. One of the key factors driving this segmental evolution is the increasing use of deep brain stimulators to treat a variety of neurological illnesses, such as obsessive-compulsive disorder, epilepsy, Parkinson's disease, essential tremor, dystonia, and Alzheimer's disease.
 

Brain Implants Market Share, By Application,

Based on application brain implants market is bifurcated into chronic pain, epilepsy, Parkinson’s disease, depression, essential tremor, Alzheimer’s Disease. The chronic pain segment is anticipated to grow over USD 6 billion by 2032. Increase in the frequency of chronic pain has initiated clinical urgency for incorporating long-term solutions. Brain implants for chronic pain are primarily used for specific conditions that have neuropathic components, such as failed back surgery syndrome, complex regional pain syndrome (CRPS), or phantom limb pain. These conditions involve altered neural signalling or nerve damage, making brain implants a potential option to modulate neural activity and reduce pain perception.
 

The brain implants market is segmented by end-use into hospitals, specialty clinics, and others. Hospitals segment dominated the industry accounting for more than 60% market share in 2022 and is estimated to witness USD 6 billion by 2032. Hospitals that offer brain implant procedures have specialized surgical facilities equipped with advanced imaging technology, such as MRI or CT scanners. These imaging tools help guide the placement of the implants precisely within the brain.
 

U.S. Brain Implants Market Size

U.S. brain implants market accounted for more than USD 1 billion in 2022.The growth is majorly attributable to increase in the frequency of neurological disorders, the presence of highly skilled medical professionals, a better understanding of available treatments, and established healthcare facilities. Additionally, it is anticipated that increased government funding and campaigns to improve awareness of movement disorders. For instance, in 2020, the Parkinson's Foundation invested approximately USD 3.5 million to support over 34 Parkinson's disease research initiatives.
 

Brain implants Market Share

Some of the notable key brain implants market players operating in the brain implants industry include

  • Boston Scientific Corporation
  • Abbott (ST. JUDE MEDICAL INC)
  • Medtronic
  • Synchron Inc
  • Renishaw PLC
  • ALEVA NEUROTHERAPEUTICS SA
  • NEVRO CORP.
  • Neuralink
  • LivaNova PLC
  • MicroTransponder Inc
     

Brain Implants Industry News:

  • In July 2022, Synchron performed the first human-brain-computer interface (BCI) implant process in the U.S. This treatment is the first to use an endovascular BCI approach in the U.S. and marks a key technological breakthrough for scalable BCI devices because it does not involve invasive open-brain surgery. Such initiative offers competitive edge to the firm in the significant market.
     

Brain implants market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

By Type (USD Million)

  • Deep brain stimulators
  • Spinal cord stimulators
  • Vagus nerve stimulators     

By Application (USD Million)

  • Chronic pain
  • Epilepsy
  • Parkinson’s disease
  • Depression
  • Essential tremor
  • Alzheimer’s disease

By End-use (USD Million)

  • Hospitals
  • Specialty clinics
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Poland
    • Switzerland
    • Norway
    • Finland
    • Sweden
    • Denmark
    • The Netherlands
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Taiwan
    • Indonesia
    • Vietnam
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE

 

Authors:  Mariam Faizullabhoy, Gauri Wani

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Frequently Asked Question(FAQ) :
What is the brain implants market worth?
Brain implants industry size was over USD 5.1 billion in 2023 and is estimated to reach more than USD 10.9 billion by 2032 due to the high prevalence of neurological disorders worldwide.
Why are deep brain stimulators gaining traction in the industry?
The deep brain stimulators type segment exceeded USD 1 billion in 2022 and will record more than USD 4 billion by 2032 owing to the increasing patient awareness of neurological movement disorder treatment.
What factors are contributing to the industry expansion in the U.S.?
U.S. brain implants market size surpassed USD 1 billion in 2022 and is estimated to grow significantly by 2032 due to the strong presence of highly skilled medical professionals and established healthcare facilities in the region.
Who are the major brain implants industry leaders?
Boston Scientific Corporation, Abbott (ST. JUDE MEDICAL INC), Medtronic, Synchron Inc, Renishaw PLC, ALEVA NEUROTHERAPEUTICS SA, NEVRO CORP., Neuralink, LivaNova PLC, and MicroTransponder Inc, are some of the key brain implant companies.
Brain Implants Market Scope
  • Brain Implants Market Size

  • Brain Implants Market Trends

  • Brain Implants Market Analysis

  • Brain Implants Market Share

Authors:  Mariam Faizullabhoy, Gauri Wani
Explore Our Licensing Options:

Starting at: $2,450

Premium Report Details:

Base Year: 2023

Companies Profiled: 10

Tables & Figures: 202

Countries Covered: 31

Pages: 100

Download Free PDF

We use cookies to enhance user experience. (Privacy Policy)